MedPath

Clinical Observational Study into Mitochondrial Oxygenation Predicting Ominous Lactate In Trajectory around Abdominal Surgery

Completed
Conditions
hepatectomy
large abdominal surgery
liver surgery
liver transplantation
10019818
Registration Number
NL-OMON49214
Lead Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Age over 18 years
Acceptable proficiency of the Dutch language
Scheduled for major abdominal surgery, the primary focus will be on liver
resection and liver transplantation surgery
Written informed consent has been signed prior to or on admission to the
surgical ward before surgery

Exclusion Criteria

Presence of mitochondrial disease
Pregnancy/lactation
Patients with skin lesions on upper arm/shoulder which impede measurements
Porphyria
Known intolerance to components of the ALA plaster
Patients uncapable of providing informed consent, due to a mental condition
interfering with the ability to understand the provided information

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>- MitoPO2 (mmHg) measured semi-continuously peri-operatively and during 48<br /><br>hours post-operatively using the automated setting of the COMET-device<br /><br>- Arterial lactate levels (mmol/l) measured four times per 24 hours or until<br /><br>available</p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath